標(biāo)題: Titlebook: Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics; Jianguo Tao,Eduardo Sotomayor Book 2012 Springer Science+Busine [打印本頁] 作者: POL 時(shí)間: 2025-3-21 17:57
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics影響因子(影響力)
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics影響因子(影響力)學(xué)科排名
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics網(wǎng)絡(luò)公開度
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics被引頻次
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics被引頻次學(xué)科排名
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics年度引用
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics年度引用學(xué)科排名
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics讀者反饋
書目名稱Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics讀者反饋學(xué)科排名
作者: 厚顏無恥 時(shí)間: 2025-3-21 20:14
Book 2012om around the world share their thoughts and knowledge about the pathobiology of hematologic cancer,as well as their view on current treatment approaches and future development in these malignant hematologic diseases. This book is well suited for hematology residents, fellows and hematology-oncology作者: Ingredient 時(shí)間: 2025-3-22 01:34
Javier Pinilla-Ibarz M.D., Ph.D.,Chih-Chi Andrew Hu Ph.D. the definition of strategies for the following themes: natural environment, agriculture and livestock farming, urban environment and wellbeing, infrastructures and mobility, cultural heritage, tourism and publ978-3-030-07205-6978-3-319-96508-6作者: 我沒有命令 時(shí)間: 2025-3-22 08:15 作者: GRACE 時(shí)間: 2025-3-22 10:16 作者: 步履蹣跚 時(shí)間: 2025-3-22 14:46
Vu Duong M.D.,Jeffrey Lancet M.D.g SMA springs, the single DOF flexible element that resists the translation along its axis can be transformed into a linear actuator that generates a stroke along its axis. Both finite-element-simulations and experimental tests were carried out to verify the mobility of the compliant parallel mechan作者: 褻瀆 時(shí)間: 2025-3-22 20:21 作者: Myocarditis 時(shí)間: 2025-3-23 00:21
Mithun Vinod Shah,Thomas P. Loughran Jr.re a few papers consider the stability of DOSs such as [214] and [215], and .. control problem has been reported in [52], which proved that the discrete-time controller approach to the continuous-time systems using delta operator.作者: 裁決 時(shí)間: 2025-3-23 01:52
Yizhuo Zhang M.D., Ph.D.,Shanqi Guo,Haifeng Zhaoliterature along this line, see for example [114, 116, 117]. Since the notion of positive realness plays a central role in systems theory [3], many researchers have considered positive real control for linear systems such as in [161, 162, 270], and references therein. The finite frequency positive r作者: antidote 時(shí)間: 2025-3-23 08:46
jump systems is an important family of systems subject to abrupt variations. The Markovian jump systems have finite modes, which may jump from one to another at different times and between different modes. A system with such a “jumping” character may be modeled as a hybrid system, and the parameter作者: 高腳酒杯 時(shí)間: 2025-3-23 13:04
Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy,n several crucial molecular pathways that support the proliferative potential of CLL. Since molecules in these pathways can contribute to proliferation, survival and chemoresistance of CLL, they are potentially useful therapeutic targets. We discussed promising methods that have been developed to ta作者: Palliation 時(shí)間: 2025-3-23 15:06 作者: Grasping 時(shí)間: 2025-3-23 21:30
Myelodysplastic Syndromes,0 it now approaches 75 per 100,000 (Cogle et al. 2011). Men are affected at a somewhat higher rate than women. There is no apparent geographical bias to the distribution of MDS; on an age-adjusted basis, the incidence is similar throughout the world, although it should be noted that these studies we作者: triptans 時(shí)間: 2025-3-23 23:14 作者: mendacity 時(shí)間: 2025-3-24 03:11 作者: Hippocampus 時(shí)間: 2025-3-24 07:14
Epigenetic Regulation and Therapy in Lymphoid Malignancies,cologically reversible, they have been regarded as optimal targets for what is now known as epigenetic therapy. In this review, we will discuss our current understanding of normal epigenetic processes, outline our knowledge of epigenetic alterations, discuss advances in the understanding of post-tra作者: lymphedema 時(shí)間: 2025-3-24 10:49
B Cell Growth, Differentiation and Malignancies,teria, viruses and other foreign insults to the human body. Each B cell makes only one distinct immunoglobulin which recognizes a cognate antigen. It is estimated that B cells in the human body can produce as many as 10. different antibodies. Thus, each B cell must undergo a series of differentiatio作者: 難理解 時(shí)間: 2025-3-24 16:33
Follicular Lymphoma: Recent Advances,astic follicles that resemble the normal GC. Normal GCB-cells do not express the anti-apoptotic protein B-cell leukemia/lymphoma 2 (BCL2) and they readily undergo apoptosis if they do not have a high affinity antigen receptor that will transmit survival signals on recognition of the antigen. The vas作者: absorbed 時(shí)間: 2025-3-24 21:15
Chronic Lymphocytic Leukemia: From Pathobiology to Targeted Therapy,r symptoms for a long period of time and require no treatment. However, malignant progression of CLL strikes indefinitely in some patients, and such CLL responds poorly to conventional chemotherapies and will eventually acquire chemoresistance. Currently, no efficient therapeutic options are availab作者: overwrought 時(shí)間: 2025-3-24 23:26 作者: extinct 時(shí)間: 2025-3-25 04:44 作者: Rodent 時(shí)間: 2025-3-25 11:30 作者: VICT 時(shí)間: 2025-3-25 15:03 作者: opalescence 時(shí)間: 2025-3-25 18:42 作者: 或者發(fā)神韻 時(shí)間: 2025-3-25 21:03 作者: Ptsd429 時(shí)間: 2025-3-26 00:45 作者: AV-node 時(shí)間: 2025-3-26 07:10 作者: BAIL 時(shí)間: 2025-3-26 12:09 作者: persistence 時(shí)間: 2025-3-26 15:14
Novel Targeted Therapeutics for Acute Myeloid Leukemia, of clonal immature myeloid cells in the bone marrow, ultimately leading to hematopoietic failure. Despite some advances in therapy for patients with adult acute myeloid leukemia, the overall prognosis remains dismal. The backbone of induction therapy has not changed in decades, and usually includes作者: Ardent 時(shí)間: 2025-3-26 19:56
Novel Targeted Therapeutics for Peripheral T-Cell Lymphoma,ogical and molecular heterogeneity (Anderson et al. 1998). They are relatively rare diseases, constituting <15 % of all NHL’s (Groves et al. 2000). The present 2008 WHO classification recognizes over 20 sub-types of mature T-cell and NK-cell malignancies (WHO 2008). These sub-types are listed in Tab作者: 匍匐 時(shí)間: 2025-3-26 23:04
,Large Granular Lymphocyte Leukemia – From Molecular Pathogenesis to Targeted Therapy,ively survey for virus-infected or transformed cells in the body. Phenotypically, LGL contain two distinct subpopulations – cytotoxic T-lymphocytes (CTL) and Natural Killer (NK) cells. Despite important differences in origin and functions, CTL share several characteristics with NK-cells (Smyth et al作者: NIP 時(shí)間: 2025-3-27 04:43 作者: 說明 時(shí)間: 2025-3-27 07:59 作者: 極力證明 時(shí)間: 2025-3-27 11:03 作者: 涂掉 時(shí)間: 2025-3-27 14:19
Alyssa Bouska,SharathKumar Bagvati,Javeed Iqbal,Basem M. William,Wing C. Chan M.Dternative measures for reducing noise, which may not be advisable for general use due to their cost or drawbacks, but which may be useful in particular cases. First, the use of buried layer in providing a noise return path will be examined. The conditions necessary for maximum efficacy, and the incr作者: Harness 時(shí)間: 2025-3-27 19:25
Javier Pinilla-Ibarz M.D., Ph.D.,Chih-Chi Andrew Hu Ph.D.s.Presents an example of multi-layered regional analysis and.The book presents a unique example of integral planning at different scales and across different types of landscapes found on the outskirts of metropolitan areas. It features a sustainability-based plan to improve the evolution of the sout作者: 無目標(biāo) 時(shí)間: 2025-3-28 00:06 作者: armistice 時(shí)間: 2025-3-28 05:25 作者: 宣稱 時(shí)間: 2025-3-28 06:48
Ling Zhang M.D.,Roger Klein M.D., Ph.D.iables. Based on the IT2 T–S fuzzy model, the criterion to design the desired controller is obtained, which guarantees the closed-loop system to be asymptotically stable and satisfies the predefined cost function. Moreover, the controller to be designed does not need to share the same premise variab作者: Graphite 時(shí)間: 2025-3-28 11:45
ádám Jóna,árpád Illés,Anas Younes M.D.t premise matching. The time-varying delay and actuator fault are first taken into account for the discrete-time IT2 fuzzy systems. The fault-tolerant controller is designed to compensate for the effect of faults by stabilizing the closed-loop system under the actuator failures. Furthermore, the sta作者: Spinous-Process 時(shí)間: 2025-3-28 15:05 作者: 無底 時(shí)間: 2025-3-28 21:40
Vu Duong M.D.,Jeffrey Lancet M.D.nd constraint space of a compliant mechanism according to the reciprocal relationship between twists and wrenches. By using the constraint-based design approach, a flexible element can be represented by the constraint wrench exerted from it. Thus by knowing the preferred mobility of a compliant mech作者: ethnology 時(shí)間: 2025-3-29 00:18 作者: 飛來飛去真休 時(shí)間: 2025-3-29 05:44
Mithun Vinod Shah,Thomas P. Loughran Jr.revious related results of the continuous and discrete systems into the framework of the DOSs framework. A class of systems in delta domain has been studied in [32, 140, 266]. The problem of system instability when the sampling time is fast can be solved by using delta operator model [49]. The delta作者: Inflamed 時(shí)間: 2025-3-29 11:18
Yizhuo Zhang M.D., Ph.D.,Shanqi Guo,Haifeng Zhaoor example a closed-loop shaping control design typically requiring small sensitivity. Weighting method has been proven useful to deal with the finite frequency requirements [150]. However, the additional weights tend to increase the system complexity and the process of selecting appropriate weights作者: Morbid 時(shí)間: 2025-3-29 12:22
alman-filter-based iterative algorithm and a recursive frequency estimator using linear prediction have been considered in [305]. In [122], the synthesis of two observer-based nonlinear control algorithms was performed within the globally linearizing control framework. A problem of optimal linear Ka作者: Mets552 時(shí)間: 2025-3-29 18:38
https://doi.org/10.1007/978-94-007-5028-9Leukemia; Lymphoma; Molecular Pathogenesis; Targeted Therapy; Apoptosis作者: 截?cái)?nbsp; 時(shí)間: 2025-3-29 21:25
Kenneth H. Shain M.D., Ph.D.,William S. Dalton Ph.D., M.D.In this chapter, . control for discrete-time switched linear systems is investigated with MDPDT switching. Based on the stability and .-gain criteria in Chap.?., the QTD controllers are designed. Here, we consider the controllers are non-fragile, which are more flexible in practice.作者: 煉油廠 時(shí)間: 2025-3-30 02:52
Jorge J. Castillo M.D.In this chapter, . filter for discrete-time switched linear systems is investigated under MDADT switching. The designed filters are both mode-dependent and QTD, which can guarantee the resulting filtering error systems are GUAS with a weighted .-gain performance.作者: 建筑師 時(shí)間: 2025-3-30 06:47 作者: 樂意 時(shí)間: 2025-3-30 11:07 作者: LITHE 時(shí)間: 2025-3-30 13:09
Richard A. Walgren M.D., Ph.D.,Josef Prchal M.D.This chapter investigates the stability of IT2 FMB control systems under imperfect premise matching. Unlike the authors’ work in [97] under PDC design concept, it was required that the IT2 fuzzy controller shares the same premise membership functions and the same number of rules as those of the IT2 T–S fuzzy model.作者: 避開 時(shí)間: 2025-3-30 18:56 作者: 符合規(guī)定 時(shí)間: 2025-3-30 21:02
978-94-007-9581-5Springer Science+Business Media Dordrecht 2012作者: encyclopedia 時(shí)間: 2025-3-31 04:31
Hematologic Cancers: From Molecular Pathobiology to Targeted Therapeutics978-94-007-5028-9Series ISSN 1871-3238 作者: 用樹皮 時(shí)間: 2025-3-31 07:03 作者: Hay-Fever 時(shí)間: 2025-3-31 11:25 作者: Recessive 時(shí)間: 2025-3-31 13:42
Molecular Biology of Mantle Cell Lymphoma,hemotherapeutic approaches. This has underscored a need for more targeted approaches to improve remission duration, salvage relapsed disease, and ultimately cure this malignancy. The following chapter will highlight progress to date in unraveling the complex biology of this disease with an emphasis on pathways amenable to targeted intervention.作者: 駕駛 時(shí)間: 2025-3-31 20:25
Pathogenesis of Non-Hodgkin Lymphoma Derived from Inflammatory, Autoimmune or Immunologic Disordersoimmune rheumatic diseases, also called autoimmune disorders, that frequently are associated with lymphomas are namely rheumatoid arthritis, Sj?rgen syndrome, systemic lupus erythematous, celiac disease, Crohn disease, and Hashimoto thyroiditis (Dias and Isenberg 2011; Tvar?zková et al. 2011; Maverakis et al. 2011; Mellemkjaer et al. 2008).作者: 最小 時(shí)間: 2025-3-31 22:39 作者: membrane 時(shí)間: 2025-4-1 02:41
Chronic Myeloproliferative Disorders:From Molecular Pathogenesis to Targeted Therapy,f safe and effective therapies will soon follow. This principle has previously been demonstrated in malignant hematology by the effectiveness of . kinase inhibitors in chronic myelogenous leukemia (CML). A new opportunity to deliver on this premise is underway in the closely related non-CML myeloproliferative neoplasms (MPNs).
